Shopping Cart 0
Cart Subtotal
USD 0

The Feinstein Institute for Medical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

The Feinstein Institute for Medical Research (Feinstein Institute), a subsidiary of Northwell Health Inc is the research institute that provides clinical research programs. The institute conducts clinical research studies for determining the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens for various diseases. It conducts research in the areas such as oncology, hematology, immunology and and autoimmune, cardiopulmonary, genetics, psychiatry, neurology and bioelectronic medicine. Feinstein Institute carries out technology transfer, and operates through clinicians and scientists. The institute operates in the areas of bioelectronic medicine, brain research, and others. Feinstein Institute is headquartered in Manhasset, New York, the US.

The Feinstein Institute for Medical Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

The Feinstein Institute for Medical Research, Medical Devices Deals, 2012 to YTD 2018 10

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 12

Merck Serono Enters Into Co-Development Agreement With Feinstein Institute For Therapy Of Inflammatory Diseases 13

Licensing Agreements 14

Applied Immunotherapeutics Enters into Licensing Agreement with Feinstein Institute 14

The Feinstein Institute for Medical Research-Key Competitors 15

The Feinstein Institute for Medical Research-Key Employees 16

The Feinstein Institute for Medical Research-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Government and Public Interest 18

Aug 27, 2018: Researcher finds new blood clot prevention strategy 18

Aug 16, 2018: Feinstein Institute researcher awarded USD 1.65M to examine vagus nerve's role in sepsis 19

Aug 16, 2018: Researcher awarded USD 1.65M to study vagus nerve's role in sepsis 20

Jul 20, 2018: Feinstein Institute Summer Concert raises USD 3M for research 21

Jul 18, 2018: Researcher awarded USD 3.5M for bladder cancer care program 22

Jul 18, 2018: Feinstein Institute researcher awarded USD 3.5M to develop bladder cancer care program 23

Jul 02, 2018: Feinstein Institute researcher uncovers new understanding of certain psychiatric diseases 24

Jul 02, 2018: Study reveals new understanding of certain psychiatric diseases 25

Jun 21, 2018: Leading mitochondrial DNA researcher discusses causes of common complex diseases at Feinstein Institute Marsh Lecture 26

Mar 27, 2018: Feinstein Institute researcher defines a part of the body as an organ 27

Mar 15, 2018: Feinstein Institute researchers discover how to better record vagus nerve signals 28

Mar 07, 2018: New blood pressure guidelines found to be harmful for some patients 29

Mar 01, 2018: Feinstein Institute researchers discover E. coli hormone reduces inflammation 30

Feb 21, 2018: Feinstein Institute, NIH release first datasets to accelerate therapies for arthritis, lupus 31

Feb 14, 2018: Feinstein Institute researcher receives USD 3.6M in grants to study rare bleeding condition 32

Jan 03, 2018: Feinstein Institute researcher awarded USD 1.2M to continue sepsis research 33

Nov 27, 2017: Feinstein Institute researchers identify new genes associated with cognitive ability 34

Oct 26, 2017: Feinstein Institute awarded over USD 1 million from the National Institutes of Health's BRAIN initiative 35

Oct 24, 2017: Breast cancer patients benefit from new pain control regimen that shortens hospital stay after reconstruction 36

Aug 11, 2017: Feinstein scientist receives NIH grant to identify genetic risks for Alzheimer's disease 37

Jul 28, 2017: Trigeminal Nerve Stimulation shows Promise for Management of Traumatic Brain Injury in Animal Study 38

Jul 14, 2017: Feinstein Institute Identifies Potential Cause for Lupus 39

Jul 14, 2017: Feinstein Investigators Awarded USD 2.8M to Study Vascular Injury After Radiation Exposure 40

Jul 10, 2017: Feinstein Institute Awarded USD 1 Million by Knapp Family Foundation to Fund Bioelectronic Medicine Research in Diabetes 41

Apr 24, 2017: Feinstein Institute and TheraSource Receive Grant to Test Novel Sepsis Therapy 42

Mar 15, 2017: Feinstein Institute Scientist Awarded USD 3M for Schizophrenia Research 43

Product News 44

Jul 20, 2017: Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent 44

Jun 04, 2018: Feinstein Institute, GE Can Read What Nerves Are Saying About Inflammation 45

Apr 11, 2017: Feinstein Institute Examines Use of an Antiparasitic Drug as New Treatment for Brain Tumors 46

Apr 11, 2017: Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors 47

Mar 19, 2018: A new, rapid and non-invasive way to diagnose endometriosis 48

Other Significant Developments 49

Sep 06, 2018: Feinstein Institute researchers find hypertension drugs could prevent memory loss in lupus patients 49

Dec 14, 2017: Feinstein Institute uses bioelectronic medicine to treat lupus 50

Appendix 51

Methodology 51

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

The Feinstein Institute for Medical Research, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Key Facts 2

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

The Feinstein Institute for Medical Research, Deals By Therapy Area, 2012 to YTD 2018 9

The Feinstein Institute for Medical Research, Medical Devices Deals, 2012 to YTD 2018 10

The Feinstein Institute for Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 12

Merck Serono Enters Into Co-Development Agreement With Feinstein Institute For Therapy Of Inflammatory Diseases 13

Applied Immunotherapeutics Enters into Licensing Agreement with Feinstein Institute 14

The Feinstein Institute for Medical Research, Key Competitors 15

The Feinstein Institute for Medical Research, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

The Feinstein Institute for Medical Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.